Human papillomavirus-associated oral intraepithelial neoplasia

Modern Pathology

Volumn 26, Issue 10, 2013, Pages 1288-1297

  Woo, Sook Bin ^a,b,c   Cashman, Emma C ^d,e   Lerman, Mark A ^a,b,c  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Pathology Services Inc Cambridge   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

HPV apoptotic oral epithelial dysplasia; Koilocytic dysplasia

Indexed keywords

PEROXIDASE; PROTEIN P16;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASIA; EPITHELIUM HYPERPLASIA; EXCISION; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; IN SITU HYBRIDIZATION; MALE; MOUTH CANCER; MOUTH CAVITY; MOUTH SQUAMOUS CELL CARCINOMA; ORAL EPITHELIAL DYSPLASIA; ORAL INTRAEPITHELIAL NEOPLASIA; PRIORITY JOURNAL; RECURRENT DISEASE; WART VIRUS;

ADULT; AGED; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 84885020418     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.70     Document Type: Article

References (44)

1. Howlader NNA, Krapcho M, Neyman N, et al. SEER Cancer Statistics Review. National Cancer Institute 1975-2008.
2. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005;103: 1843-1849.
3. Patel SC, Carpenter WR, Tyree S, et al. Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol 2011;29: 1488-1494.
4. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356: 1944-1956.
5. El-Mofty SK. Human papillomavirus (HPV) related carcinomas of the upper aerodigestive tract. Head Neck Pathol 2007;1: 181-185.
6. Chung CH, GillisonML. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res 2009;15: 6758-6762.
7. Chernock RD, Lewis JS Jr, Zhang Q, et al. Human papillomavirus-positive basaloid squamous cell carcinomas of the upper aerodigestive tract: a distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma. Hum Pathol 2010;41: 1016-1023.
8. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29: 4294-4301.
9. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363: 24-35.
10. Ha PK, Pai SI, Westra WH, et al. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 2002;8: 1203-1209.
11. Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003;95: 1772-1783.
12. Jayaprakash V, Reid M, Hatton E, et al. Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010. Oral Oncol 2011;47: 1048-1054.
13. Gale N, Pilch BZ, Sidransky D, et al. Epithelial precursor lesions, In: Barnes LEJ, Reichart P, Sidransky D(eds). World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. IARC Press: Lyon, France; 2005, pp 140-143.
14. Warnakulasuriya S, Reibel J, Bouquot J, et al. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 2008;37: 127-133.
15. Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012;307: 693-703.
16. Syrjanen S, Lodi G, von Bultzingslowen I, et al. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis 2011;17(Suppl 1): 58-72.
17. Zeuss MS, Miller CS, White DK. In situ hybridization analysis of human papillomavirus DNA in oral mucosal lesions. Oral Surg Oral Med Oral Pathol 1991; 71: 714-720.
18. Fouret P, Martin F, Flahault A, et al. Human papillomavirus infection in the malignant and premalignant head and neck epithelium. Diagn Mol Pathol 1995;4: 122-127.
19. D'Costa J, Saranath D, Dedhia P, et al. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 1998;34: 413-420.
20. Bouda M, Gorgoulis VG, Kastrinakis NG, et al. 'High risk' HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol 2000;13: 644-653.
21. Pannone G, Rodolico V, Santoro A, et al. Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 immunohistochemistry, consensus PCR HPV-DNA, and in situ hybridization. Infect Agent Cancer 2012; 7: 4.
22. Ishibashi M, Kishino M, Sato S, et al. The prevalence of human papillomavirus in oral premalignant lesions and squamous cell carcinoma in comparison to cervical lesions used as a positive control. Int J Clin Oncol 2011;16: 646-653.
23. Angiero F, Gatta LB, Seramondi R, et al. Frequency and role of HPV in the progression of epithelial dysplasia to oral cancer. Anticancer Res 2010;30: 3435-3440.
24. Konig F, Krekeler G, Honig JF, et al. Relation between human papillomavirus positivity and p16 expression in head and neck carcinomas - a tissue microarray study. Anticancer Res 2007;27: 283-288.
25. Cunningham LL Jr., Pagano GM, Li M, et al. Overexpression of p16INK4 is a reliable marker of human papillomavirus-induced oral high-grade squamous dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102: 77-81.
26. Buajeeb W, Poomsawat S, Punyasingh J, et al. Expression of p16 in oral cancer and premalignant lesions. J Oral Pathol Med 2009;38: 104-108.
27. Fonseca-Silva T, Farias LC, Cardoso CM, et al. Analysis of p16(CDKN2A) methylation and HPV-16 infection in oral mucosal dysplasia. Pathobiology 2012;79: 94-100.
28. Darragh TM, Colgan TJ, Cox JT, et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med 2012;136: 1266-1297.
29. Kuffer R, Lombardi T. Premalignant lesions of the oral mucosa. A discussion about the place of oral intraepithelial neoplasia (OIN). Oral Oncol 2002;38: 125-130.
30. Kujan O, Oliver RJ, Khattab A, et al. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol 2006;42: 987-993.
31. Fornatora M, Jones AC, Kerpel S, et al. Human papillomavirus-associated oral epithelial dysplasia (koilocytic dysplasia): an entity of unknown biologic potential. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82: 47-56.
32. Kratochvil FJ, Cioffi GA, Auclair PL, et al. Virusassociated dysplasia (bowenoid papulosis?) of the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1989;68: 312-316.
33. Daley T, Birek C, Wysocki GP. Oral bowenoid lesions: differential diagnosis and pathogenetic insights. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90: 466-473.
34. Rinaggio J, Glick M, Lambert WC. Oral bowenoid papulosis in an HIV-positive male. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101: 328-332.
35. Klingbeil MF, De Lima MD, Gallottini MH, et al. Oral koilocytic dysplasia: long-term clinical control. A case report. Minerva Stomatol 2012;61: 288-293.
36. Willman JH, Heinz D, Golitz LE, et al. Correlation of p16 and pRb expression with HPV detection in Bowen's disease. J Cutan Pathol 2006;33: 629-633.
37. Auepemkiate S, Thongsuksai P, Boonyaphiphat P. P16(INK4A) expression in Bowen's disease and Bowenoid papulosis. J Med Assoc Thai 2006;89: 1460-1465.
38. Liu H, Urabe K, Moroi Y, et al. Expression of p16 and hTERT protein is associated with the presence of highrisk human papillomavirus in Bowenoid papulosis. J Cutan Pathol 2006;33: 551-558.
39. Wikstrom A, Hedblad MA, Syrjanen S. Penile intraepithelial neoplasia: histopathological evaluation, HPV typing, clinical presentation and treatment. J Eur Acad Dermatol Venereol 2012;26: 325-330.
40. Cuberos V, Perez J, Lopez CJ, et al. Molecular and serological evidence of the epidemiological association of HPV 13 with focal epithelial hyperplasia: a casecontrol study. J Clin Virol 2006;37: 21-26.
41. Gonzalez LV, Gaviria AM, Sanclemente G, et al. Clinical, histopathological and virological findings in patients with focal epithelial hyperplasia from Colombia. Int J Dermatol 2005;44: 274-279.
42. El-Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 2003;27: 1463-1470.
43. Lewis JS Jr., Thorstad WL, Chernock RD, et al. p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol 2010;34: 1088-1096.
44. Marur S, D'Souza G, Westra WH, et al. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010;11: 781-789.